Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 16 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Convalescent Plasma Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.

This report studies the global Convalescent Plasma Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Convalescent Plasma Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Convalescent Plasma Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Convalescent Plasma Therapy total market, 2018-2029, (USD Million)
Global Convalescent Plasma Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Convalescent Plasma Therapy total market, key domestic companies and share, (USD Million)
Global Convalescent Plasma Therapy revenue by player and market share 2018-2023, (USD Million)
Global Convalescent Plasma Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Convalescent Plasma Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Convalescent Plasma Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring and Takeda Pharmaceutical Company Limited, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Convalescent Plasma Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Convalescent Plasma Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Convalescent Plasma Therapy Market, Segmentation by Type
    IgM
    IgG
    IgA

Global Convalescent Plasma Therapy Market, Segmentation by Application
    Prophylaxis
    Treatment

Companies Profiled:
    Bio Farma
    Grifols
    Hilton Pharma
    Biotest
    BPL
    LFB
    Octapharma
    CSL Behring
    Takeda Pharmaceutical Company Limited
    Orthosera Kft

Key Questions Answered
1. How big is the global Convalescent Plasma Therapy market?
2. What is the demand of the global Convalescent Plasma Therapy market?
3. What is the year over year growth of the global Convalescent Plasma Therapy market?
4. What is the total value of the global Convalescent Plasma Therapy market?
5. Who are the major players in the global Convalescent Plasma Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Convalescent Plasma Therapy Introduction
    1.2 World Convalescent Plasma Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Convalescent Plasma Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Convalescent Plasma Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Convalescent Plasma Therapy Market Size (2018-2029)
        1.3.3 China Convalescent Plasma Therapy Market Size (2018-2029)
        1.3.4 Europe Convalescent Plasma Therapy Market Size (2018-2029)
        1.3.5 Japan Convalescent Plasma Therapy Market Size (2018-2029)
        1.3.6 South Korea Convalescent Plasma Therapy Market Size (2018-2029)
        1.3.7 ASEAN Convalescent Plasma Therapy Market Size (2018-2029)
        1.3.8 India Convalescent Plasma Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Convalescent Plasma Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Convalescent Plasma Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.2 World Convalescent Plasma Therapy Consumption Value by Region
        2.2.1 World Convalescent Plasma Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Convalescent Plasma Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.4 China Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.5 Europe Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.6 Japan Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.7 South Korea Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.8 ASEAN Convalescent Plasma Therapy Consumption Value (2018-2029)
    2.9 India Convalescent Plasma Therapy Consumption Value (2018-2029)

3 World Convalescent Plasma Therapy Companies Competitive Analysis
    3.1 World Convalescent Plasma Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Convalescent Plasma Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Convalescent Plasma Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Convalescent Plasma Therapy in 2022
    3.3 Convalescent Plasma Therapy Company Evaluation Quadrant
    3.4 Convalescent Plasma Therapy Market: Overall Company Footprint Analysis
        3.4.1 Convalescent Plasma Therapy Market: Region Footprint
        3.4.2 Convalescent Plasma Therapy Market: Company Product Type Footprint
        3.4.3 Convalescent Plasma Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Convalescent Plasma Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Convalescent Plasma Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Convalescent Plasma Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Convalescent Plasma Therapy Consumption Value Comparison
        4.2.1 United States VS China: Convalescent Plasma Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Convalescent Plasma Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Convalescent Plasma Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Convalescent Plasma Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Convalescent Plasma Therapy Revenue, (2018-2023)
    4.4 China Based Companies Convalescent Plasma Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Convalescent Plasma Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Convalescent Plasma Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Convalescent Plasma Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Convalescent Plasma Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Convalescent Plasma Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Convalescent Plasma Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 IgM
        5.2.2 IgG
        5.2.3 IgA
    5.3 Market Segment by Type
        5.3.1 World Convalescent Plasma Therapy Market Size by Type (2018-2023)
        5.3.2 World Convalescent Plasma Therapy Market Size by Type (2024-2029)
        5.3.3 World Convalescent Plasma Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Convalescent Plasma Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Prophylaxis
        6.2.2 Treatment
    6.3 Market Segment by Application
        6.3.1 World Convalescent Plasma Therapy Market Size by Application (2018-2023)
        6.3.2 World Convalescent Plasma Therapy Market Size by Application (2024-2029)
        6.3.3 World Convalescent Plasma Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Bio Farma
        7.1.1 Bio Farma Details
        7.1.2 Bio Farma Major Business
        7.1.3 Bio Farma Convalescent Plasma Therapy Product and Services
        7.1.4 Bio Farma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Bio Farma Recent Developments/Updates
        7.1.6 Bio Farma Competitive Strengths & Weaknesses
    7.2 Grifols
        7.2.1 Grifols Details
        7.2.2 Grifols Major Business
        7.2.3 Grifols Convalescent Plasma Therapy Product and Services
        7.2.4 Grifols Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Grifols Recent Developments/Updates
        7.2.6 Grifols Competitive Strengths & Weaknesses
    7.3 Hilton Pharma
        7.3.1 Hilton Pharma Details
        7.3.2 Hilton Pharma Major Business
        7.3.3 Hilton Pharma Convalescent Plasma Therapy Product and Services
        7.3.4 Hilton Pharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Hilton Pharma Recent Developments/Updates
        7.3.6 Hilton Pharma Competitive Strengths & Weaknesses
    7.4 Biotest
        7.4.1 Biotest Details
        7.4.2 Biotest Major Business
        7.4.3 Biotest Convalescent Plasma Therapy Product and Services
        7.4.4 Biotest Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Biotest Recent Developments/Updates
        7.4.6 Biotest Competitive Strengths & Weaknesses
    7.5 BPL
        7.5.1 BPL Details
        7.5.2 BPL Major Business
        7.5.3 BPL Convalescent Plasma Therapy Product and Services
        7.5.4 BPL Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 BPL Recent Developments/Updates
        7.5.6 BPL Competitive Strengths & Weaknesses
    7.6 LFB
        7.6.1 LFB Details
        7.6.2 LFB Major Business
        7.6.3 LFB Convalescent Plasma Therapy Product and Services
        7.6.4 LFB Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 LFB Recent Developments/Updates
        7.6.6 LFB Competitive Strengths & Weaknesses
    7.7 Octapharma
        7.7.1 Octapharma Details
        7.7.2 Octapharma Major Business
        7.7.3 Octapharma Convalescent Plasma Therapy Product and Services
        7.7.4 Octapharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Octapharma Recent Developments/Updates
        7.7.6 Octapharma Competitive Strengths & Weaknesses
    7.8 CSL Behring
        7.8.1 CSL Behring Details
        7.8.2 CSL Behring Major Business
        7.8.3 CSL Behring Convalescent Plasma Therapy Product and Services
        7.8.4 CSL Behring Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 CSL Behring Recent Developments/Updates
        7.8.6 CSL Behring Competitive Strengths & Weaknesses
    7.9 Takeda Pharmaceutical Company Limited
        7.9.1 Takeda Pharmaceutical Company Limited Details
        7.9.2 Takeda Pharmaceutical Company Limited Major Business
        7.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Services
        7.9.4 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
        7.9.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
    7.10 Orthosera Kft
        7.10.1 Orthosera Kft Details
        7.10.2 Orthosera Kft Major Business
        7.10.3 Orthosera Kft Convalescent Plasma Therapy Product and Services
        7.10.4 Orthosera Kft Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Orthosera Kft Recent Developments/Updates
        7.10.6 Orthosera Kft Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Convalescent Plasma Therapy Industry Chain
    8.2 Convalescent Plasma Therapy Upstream Analysis
    8.3 Convalescent Plasma Therapy Midstream Analysis
    8.4 Convalescent Plasma Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Convalescent Plasma Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Convalescent Plasma Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Convalescent Plasma Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Convalescent Plasma Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Convalescent Plasma Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Convalescent Plasma Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Convalescent Plasma Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Convalescent Plasma Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Convalescent Plasma Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Convalescent Plasma Therapy Players in 2022
    Table 12. World Convalescent Plasma Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Convalescent Plasma Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Convalescent Plasma Therapy Player
    Table 15. Convalescent Plasma Therapy Market: Company Product Type Footprint
    Table 16. Convalescent Plasma Therapy Market: Company Product Application Footprint
    Table 17. Convalescent Plasma Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Convalescent Plasma Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Convalescent Plasma Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Convalescent Plasma Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Convalescent Plasma Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Convalescent Plasma Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Convalescent Plasma Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Convalescent Plasma Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Convalescent Plasma Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Convalescent Plasma Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Convalescent Plasma Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Convalescent Plasma Therapy Revenue Market Share (2018-2023)
    Table 29. World Convalescent Plasma Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Convalescent Plasma Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Convalescent Plasma Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Convalescent Plasma Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Convalescent Plasma Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Convalescent Plasma Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Bio Farma Basic Information, Area Served and Competitors
    Table 36. Bio Farma Major Business
    Table 37. Bio Farma Convalescent Plasma Therapy Product and Services
    Table 38. Bio Farma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Bio Farma Recent Developments/Updates
    Table 40. Bio Farma Competitive Strengths & Weaknesses
    Table 41. Grifols Basic Information, Area Served and Competitors
    Table 42. Grifols Major Business
    Table 43. Grifols Convalescent Plasma Therapy Product and Services
    Table 44. Grifols Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Grifols Recent Developments/Updates
    Table 46. Grifols Competitive Strengths & Weaknesses
    Table 47. Hilton Pharma Basic Information, Area Served and Competitors
    Table 48. Hilton Pharma Major Business
    Table 49. Hilton Pharma Convalescent Plasma Therapy Product and Services
    Table 50. Hilton Pharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Hilton Pharma Recent Developments/Updates
    Table 52. Hilton Pharma Competitive Strengths & Weaknesses
    Table 53. Biotest Basic Information, Area Served and Competitors
    Table 54. Biotest Major Business
    Table 55. Biotest Convalescent Plasma Therapy Product and Services
    Table 56. Biotest Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Biotest Recent Developments/Updates
    Table 58. Biotest Competitive Strengths & Weaknesses
    Table 59. BPL Basic Information, Area Served and Competitors
    Table 60. BPL Major Business
    Table 61. BPL Convalescent Plasma Therapy Product and Services
    Table 62. BPL Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. BPL Recent Developments/Updates
    Table 64. BPL Competitive Strengths & Weaknesses
    Table 65. LFB Basic Information, Area Served and Competitors
    Table 66. LFB Major Business
    Table 67. LFB Convalescent Plasma Therapy Product and Services
    Table 68. LFB Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. LFB Recent Developments/Updates
    Table 70. LFB Competitive Strengths & Weaknesses
    Table 71. Octapharma Basic Information, Area Served and Competitors
    Table 72. Octapharma Major Business
    Table 73. Octapharma Convalescent Plasma Therapy Product and Services
    Table 74. Octapharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Octapharma Recent Developments/Updates
    Table 76. Octapharma Competitive Strengths & Weaknesses
    Table 77. CSL Behring Basic Information, Area Served and Competitors
    Table 78. CSL Behring Major Business
    Table 79. CSL Behring Convalescent Plasma Therapy Product and Services
    Table 80. CSL Behring Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. CSL Behring Recent Developments/Updates
    Table 82. CSL Behring Competitive Strengths & Weaknesses
    Table 83. Takeda Pharmaceutical Company Limited Basic Information, Area Served and Competitors
    Table 84. Takeda Pharmaceutical Company Limited Major Business
    Table 85. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Services
    Table 86. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Takeda Pharmaceutical Company Limited Recent Developments/Updates
    Table 88. Orthosera Kft Basic Information, Area Served and Competitors
    Table 89. Orthosera Kft Major Business
    Table 90. Orthosera Kft Convalescent Plasma Therapy Product and Services
    Table 91. Orthosera Kft Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Convalescent Plasma Therapy Upstream (Raw Materials)
    Table 93. Convalescent Plasma Therapy Typical Customers
List of Figure
    Figure 1. Convalescent Plasma Therapy Picture
    Figure 2. World Convalescent Plasma Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Convalescent Plasma Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Convalescent Plasma Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Convalescent Plasma Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Convalescent Plasma Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Convalescent Plasma Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Convalescent Plasma Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Convalescent Plasma Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Convalescent Plasma Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Convalescent Plasma Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Convalescent Plasma Therapy Markets in 2022
    Figure 27. United States VS China: Convalescent Plasma Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Convalescent Plasma Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Convalescent Plasma Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Convalescent Plasma Therapy Market Size Market Share by Type in 2022
    Figure 31. IgM
    Figure 32. IgG
    Figure 33. IgA
    Figure 34. World Convalescent Plasma Therapy Market Size Market Share by Type (2018-2029)
    Figure 35. World Convalescent Plasma Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Convalescent Plasma Therapy Market Size Market Share by Application in 2022
    Figure 37. Prophylaxis
    Figure 38. Treatment
    Figure 39. Convalescent Plasma Therapy Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Convalescent Plasma Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Convalescent Plasma Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 13 Jan 2023

date Medical Care

Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.

Global Convalescent Plasma Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Convalescent Plasma Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Convalescent Plasma Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2024-2030

Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Medical Care

The global Convalescent Plasma Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Convalescent Plasma Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>